The Healey-Driscoll Administration and the Massachusetts Life Sciences Center (MLSC) have launched BioBoost, a program intended to provide funding to expand biomanufacturing and medtech advanced manufacturing operations across Massachusetts. Some $60 million in funding requests came into the program, which has a $3.5-million budget.

Largest of the five grants awarded was $1.4 million to Woburn-based Terrestrial. The funding will support the buildout of what is reportedly the world’s first commercial-scale therapeutic microarray patch manufacturing headquarters. Other grants went to Massachusetts Biomedical Initiatives, RoslinCT, Holobiome and Theromics Inc.

“Expanding manufacturing capacity is essential to sustaining growth in Massachusetts’ life sciences ecosystem,” said Undersecretary of Business Strategies Zenobia Moochhala. “These investments will help companies move faster, create high-quality jobs, and build a more resilient production pipeline across the Commonwealth.”  

Since 2008, the MLSC has deployed more than $1.1 billion in Massachusetts through grants, loans, capital infrastructure investments, tax incentives and workforce development programs